• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US

expresspharmaJune 24, 2021

Tag: Dr Reddy’s , Icosapent Ethyl capsules , triglyceride

Dr Reddy’s Laboratories 21st launched Icosapent Ethyl capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market.

Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US

The company has launched the capsules in one gram strength after approval by the US Food and Drug Administration (USFDA), the company said in a regulatory filing.

Dr Reddy’s Icosapent Ethyl is available in one gram capsules in a bottle count size of 120’s count. It is approved as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.

Previous:Turkish COVID-19 vaccine starts phase-III trials

Next:Adroit Biomed develops orally-dissolving mini effervescent tablet to prevent, manage and recover from COVID-19

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Medium Chain Triglyceride

Medium Chain Triglyceride
Medium chain triglyceride microcapsule powder

Medium chain triglyceride microcapsule powder
Medium chain triglycerides Powder(palm oil)

Medium chain triglycerides Powder(palm oil)
Triglyceride

Triglyceride
Medium chain triglycerides Powder(Coconut oil)

Medium chain triglycerides Powder(Coconut oil)
Sinomega Omega-3 Refined Fish Oil EPA18/DHA12 Triglycerides

Sinomega Omega-3 Refined Fish Oil EPA18/DHA12 Triglycerides
Miglyol -812 (triglycerides of capric/caprylic acids)

Miglyol -812 (triglycerides of capric/caprylic acids)
omega-3-acid triglycerides

omega-3-acid triglycerides
Omega-3 Triglycerides

Omega-3 Triglycerides
Conjugated Linoleic Acid-Triglyceride

Conjugated Linoleic Acid-Triglyceride

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service